Merck trial shows more melanoma cancer patients respond to drug
(Reuters) - Early data from a small trial of Merck & Co Inc's experimental immunotherapy cancer drug, known as MK-3475, show that about half of advanc...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/Xps60XM9j_o/story01.htm
No comments:
Post a Comment